Cathay Industrial Biotech withdraws $90 million IPO

By Renaissance Capital,

Shutterstock photo

Cathay Industrial Biotech, a Chinese producer of biobutanol and LCDAs used in chemical and fuel markets, withdrew its plans for an initial public offering on Monday. The Shanghai, China-based company, which was founded in 1997, originally postponed its IPO in August 2011. The company was planning on raising $90 million by offering 6.9 million shares at a price range of $12 to $14. Morgan Stanley, Deutsche Bank Securities and Jefferies & Co. were set to be the joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines IPOs
Referenced Stocks: CBIO

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by